To achieve this progress, biologic production has had to reinvent itself. Although biologics were once sourced directly from donated blood plasma or cells, the backbone of this process is now a ...

Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs present new challenges.

B cells were first characterized in the 1960s and early 1970s, when Max Cooper and Robert Good showed that surgical removal of the bursa of Fabricius (a primary immune organ in birds) rendered ...

Researchers suggest that MultiCell could potentially be used to discern early patterns of disease, such as in asthma.